Alpha Tau Medical Ltd. (DRTS)

NASDAQ: DRTS · Delayed Price · USD
6.22
-0.72 (-10.37%)
At close: May 17, 2022 4:00 PM
6.38
0.16 (2.57%)
After-hours:May 17, 2022 4:00 PM EDT
Market Cap425.95M
Revenue (ttm)n/a
Net Income (ttm)-27.27M
Shares Out68.48M
EPS (ttm)-0.67
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume34,050
Open6.94
Previous Close6.94
Day's Range6.15 - 7.63
52-Week Range4.68 - 20.65
Betan/a
AnalystsBuy
Price Target19.89 (+219.8%)
Earnings DateJun 27, 2022

About DRTS

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.

IndustryBiotechnology
Founded2015
Employees83
Stock ExchangeNASDAQ
Ticker SymbolDRTS
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 10 analysts, the average rating for DRTS stock is "Buy." The 12-month stock price forecast is 19.89, which is an increase of 219.77% from the latest price.

Price Target
$19.89
(219.77% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Alpha Tau Medical Announces Full Year 2021 Financial Results and Provides Corporate Update

JERUSALEM, March 28, 2022 /PRNewswire/ -- Alpha Tau Medical Ltd. (Nasdaq: DRTS) (Nasdaq: DRTSW), ("Alpha Tau" or the "Company"), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT...

1 month ago - PRNewsWire

12 Stocks Halted On A Circuit Breaker This Week

A circuit breaker is an automatic, temporary trading halt on certain securities when the underlying stock is experiencing times of high volatility. It is a measure put in place to help restore, and brin...

1 month ago - Benzinga

Why Alpha Tau Medical Stock Skyrocketed Today

The stock enjoyed another big gain.

1 month ago - The Motley Fool

Alpha Tau Medical and Healthcare Capital Corp. Announce Completion of Business Combination

JERUSALEM and WILMINGTON, Del., March 7, 2022 /PRNewswire/ -- Alpha Tau Medical Ltd.

2 months ago - PRNewsWire

Alpha Tau Announces New Research Collaboration to Study the Potential of Alpha DaRT to Enhance Immune Stimulation in ...

JERUSALEM, Jan. 20, 2022 /PRNewswire/ -- Alpha Tau Medical Ltd. ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced today that it has signed a sponsored ...

3 months ago - PRNewsWire

Healthcare Capital Corp Announces Special Meeting Date for Proposed Business Combination with Alpha Tau Medical Ltd.

NEW YORK, New York and JERUSALEM, Israel, Jan. 19, 2022 (GLOBE NEWSWIRE) -- Healthcare Capital Corp (NASDAQ: HCCC, HCCCW, and HCCCU) (“HCCC”) today announced that on January 12, 2022, the U.S. Securitie...

3 months ago - GlobeNewsWire

Alpha Tau Announces Completion of Enrollment of Japanese Pivotal Clinical Trial in Recurrent Head & Neck Cancer

JERUSALEM, Jan. 3, 2022 /PRNewswire/ -- Alpha Tau Medical Ltd. ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced today that it has been notified by Hek...

4 months ago - PRNewsWire

Alpha Tau Announces Enrollment of First Patient in Combination Trial of Alpha DaRT™ and Pembrolizumab (Keytruda®)

JERUSALEM, Nov. 3, 2021 /PRNewswire/ -- Alpha Tau Medical Ltd. ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT, announced today that it has enrolled its first pa...

6 months ago - PRNewsWire

Alpha Tau Announces Completion of Enrollment in First US Clinical Trial of Alpha DaRT™ and Achievement of First Prima...

JERUSALEM, Oct. 25, 2021 /PRNewswire/ -- Alpha Tau Medical Ltd. ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT, announced today that its US pilot trial for skin...

6 months ago - PRNewsWire

Alpha Tau and Healthcare Capital Corp. to Combine and Create A Publicly Traded Company Focused on Transforming the Tr...

- Alpha Tau's proprietary Alpha DaRT™ is designed to deliver uniquely potent alpha radiation to destroy solid tumors with localized precision, sparing surrounding healthy tissue, thereby maintaining can...

10 months ago - PRNewsWire